|
Ed Acosta, Pharm.D. (Bio)
Pediatrics
University of Alabama at Birmingham
Brian Boyle, M.D. (Bio)
HIV/Hepatitis B&C Co-infection
Cornell University Medical College
The New York Presbyterian Hospital
David M. Burger, Pharm.D., Ph.D. (Bio)
Therapeutic Drug Monitoring,
International Perspectives
University Medical Centre Nijmegen
The Netherlands
Patrick Clay, Pharm.D. (Bio)
Pharmacoeconomics
Kansas City Free Clinic
Diana Clarke, Pharm.D. (Bio)
Pediatrics in HIV Therapy
Boston Medical Center
David Haas, M.D. (Bio)
Pharmacogenomics
Vanderbilt University
Katherine Graham, Pharm.D. (Bio)
Patient Management
North Broward County Clinic
Helene Hardy-Harris, Pharm.D. (Bio)
Toxicity
Boston Medical Center
Chiedza Maponga, Pharm.D., MHPE (Bio)
International Perspectives
University of Zimbabwe, University At Buffalo
Robert Murphy, M.D. (Bio)
Complications and Toxicity
Northeastern University
Concepta A. Merry, Ph.D., M.S. (Bio)
Therapeutic Drug Monitoring, International Perspectives
National Pharmacoeconomics Center, St. James Hospital
Dublin, Ireland
Jeffrey P. Nadler, M.D.,FACP (Bio)
Antiretroviral Toxicity
College of Medicine, University of South Florida
John Rodman, Pharm.D. (Bio)
Pediatrics
St. Jude Children's Research Hospital
|